Literature DB >> 14623051

Expression and function of TNF-family proteins and receptors in human osteoblasts.

Rongfa Bu1, Christopher W Borysenko, Yanan Li, Lihuan Cao, Afsie Sabokbar, Harry C Blair.   

Abstract

We studied how tumor necrosis-factor (TNF)-family proteins interact with osteoblasts to resolve several controversial points. We measured expression of TNFs, TNF-receptors, and nonsignaling (decoy) TNF receptors in human osteoblasts derived from mesenchymal stem cells and in MG63 human osteosarcoma cells using unamplified mRNA screening, with secondary Western or PCR analysis where indicated, and studied the effects of TNFs on osteoblasts in cell culture. Expression of TNFs and receptors was similar in MG63 cells and osteoblasts. TNF-R1 (p55), TRAIL receptor 1 and 2 (DR4 and 5), and Fas were expressed; RANK was undetectable. TNF-family ligands RANKL, TRAIL, and TNFalpha were expressed, but mRNAs were typically at low levels relative to receptors, suggesting that osteoblastic TNF signals, including RANKL, require specific stimuli. Flow cytometry of MG63 cells confirmed TNFalpha receptors and identified subpopulations with high surface-bound TNFalpha. Decoy receptors expressed included a novel soluble form of TNFRSF25 (formerly DR3 or Apo3), implicated in rheumatoid-arthritis linkage studies, as well as osteoprotegerin, a well-characterized osteoblast protein that binds TRAIL and RANKL, and DcR2, which binds TRAIL. Osteoblast apoptosis was studied using terminal deoxynucleotidyl transferase labeling and annexin V binding. MG63 cells were resistant to apoptosis by exogenous TNFalpha except when grown in media promoting osteoblast-like growth or matrix nodules. However, in media supporting osteoblast-like phenotype, apoptosis was induced by anti-Fas or TNF, in contrast to other studies with human osteoblasts. TRAIL caused cell retraction, supporting functional TRAIL response in cell differentiation, but did not cause apoptosis. We conclude that human osteoblasts have functional receptors for FasL, TNFalpha, TRAIL, but not RANKL, and that osteoblasts are protected by multiple nonsignaling TNF receptors against destruction by TNF-family proteins under conditions favoring cell growth.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14623051     DOI: 10.1016/j.bone.2003.07.006

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  28 in total

1.  FSH-receptor isoforms and FSH-dependent gene transcription in human monocytes and osteoclasts.

Authors:  Lisa J Robinson; Irina Tourkova; Yujuan Wang; Allison C Sharrow; Michael S Landau; Beatrice B Yaroslavskiy; Li Sun; Mone Zaidi; Harry C Blair
Journal:  Biochem Biophys Res Commun       Date:  2010-02-19       Impact factor: 3.575

2.  Selective targeting of death receptor 5 circumvents resistance of MG-63 osteosarcoma cells to TRAIL-induced apoptosis.

Authors:  Rachel M Locklin; Ermanno Federici; Belen Espina; Philippa A Hulley; R Graham G Russell; Claire M Edwards
Journal:  Mol Cancer Ther       Date:  2007-12-07       Impact factor: 6.261

Review 3.  The roles of lipid oxidation products and receptor activator of nuclear factor-κB signaling in atherosclerotic calcification.

Authors:  Linda Demer; Yin Tintut
Journal:  Circ Res       Date:  2011-06-10       Impact factor: 17.367

4.  Osteoblast Differentiation and Bone Matrix Formation In Vivo and In Vitro.

Authors:  Harry C Blair; Quitterie C Larrouture; Yanan Li; Hang Lin; Donna Beer-Stoltz; Li Liu; Rocky S Tuan; Lisa J Robinson; Paul H Schlesinger; Deborah J Nelson
Journal:  Tissue Eng Part B Rev       Date:  2016-12-27       Impact factor: 6.389

5.  RANK-Fc inhibits malignancy via inhibiting ERK activation and evoking caspase-3-mediated anoikis in human osteosarcoma cells.

Authors:  Toru Akiyama; Peter F M Choong; Crispin R Dass
Journal:  Clin Exp Metastasis       Date:  2010-04-11       Impact factor: 5.150

6.  Alteration of newly induced endochondral bone formation in adult mice without tumour necrosis factor receptor 1.

Authors:  I K Lukić; D Grcević; N Kovacić; V Katavić; S Ivcević; I Kalajzić; A Marusić
Journal:  Clin Exp Immunol       Date:  2005-02       Impact factor: 4.330

Review 7.  Interaction of staphylococci with bone.

Authors:  John A Wright; Sean P Nair
Journal:  Int J Med Microbiol       Date:  2009-11-03       Impact factor: 3.473

Review 8.  Periodontal Ligament and Alveolar Bone in Health and Adaptation: Tooth Movement.

Authors:  Nan Jiang; Weihua Guo; Mo Chen; Ying Zheng; Jian Zhou; Sahng Gyoon Kim; Mildred C Embree; Karen Songhee Song; Heloisa F Marao; Jeremy J Mao
Journal:  Front Oral Biol       Date:  2015-11-24

9.  Modulation of osteoblast gap junction connectivity by serum, TNFalpha, and TRAIL.

Authors:  Allison C Sharrow; Yanan Li; Amanda Micsenyi; Reed D Griswold; Alan Wells; Satdarshan S P Monga; Harry C Blair
Journal:  Exp Cell Res       Date:  2007-10-23       Impact factor: 3.905

10.  Fas receptor is required for estrogen deficiency-induced bone loss in mice.

Authors:  Natasa Kovacic; Danka Grcevic; Vedran Katavic; Ivan Kresimir Lukic; Vladimir Grubisic; Karlo Mihovilovic; Hrvoje Cvija; Peter Ian Croucher; Ana Marusic
Journal:  Lab Invest       Date:  2010-01-18       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.